Evidence map›Paper›PMID 30854685›Full record

ArticleEquine veterinary journal2019

Effect of different doses of inhaled ciclesonide on lung function, clinical signs related to airflow limitation and serum cortisol levels in horses with experimentally induced mild to severe airway obstruction.

J-P Lavoie, M Bullone, N Rodrigues, P Germim, B Albrecht, M von Salis-Soglio

Open access · hybridAbstract readClinical Trial, Veterinary
In one paragraph

Article in Equine veterinary journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
7.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Frontiers in immunology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. A CONSORT-guided, randomized, double-blind, controlled pilot clinical trial of inhaled lidocaine for the treatment of equine asthma.Canadian journal of veterinary research = Revue canadienne de recherche veterinaire · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Glucocorticoid treatment in horses with asthma: A narrative review.Journal of veterinary internal medicine · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 3 countries.

J-P LavoieDepartment of Clinical Sciences, Université de Montréal, St-Hyacinthe, Quebec, Canada.ORCID https://orcid.org/0000-0003-4655-2102
M BulloneDepartment of Clinical Sciences, Université de Montréal, St-Hyacinthe, Quebec, Canada.ORCID https://orcid.org/0000-0002-9094-6734
N RodriguesDepartment of Clinical Sciences, Université de Montréal, St-Hyacinthe, Quebec, Canada.
P GermimDepartment of Clinical Sciences, Université de Montréal, St-Hyacinthe, Quebec, Canada.
B AlbrechtBoehringer Ingelheim Vetmedica GmbH, Ingelheim am Rhein, Germany.
M von Salis-SoglioBoehringer Ingelheim Vetmedica GmbH, Ingelheim am Rhein, Germany.
Université de Montréal · CABoehringer Ingelheim (Germany) · DE

Funding

Boehringer Ingelheim Vetmedica GmbH
6 · The paper itself

Abstract

backgroundInhaled corticosteroids are effective for the treatment of equine asthma but they induce cortisol suppression with potential side effects.

objectivesTo study the efficacy of ciclesonide, an inhaled corticosteroid with an improved safety profile, on lung function, clinical signs related to airway obstruction, and serum cortisol levels in asthmatic horses exposed to a mouldy hay challenge. STUDY

designCross-over placebo controlled, blinded, randomised experiment.

methodsSixteen horses were enrolled in three subsequent dose-titration studies (8 horses/study) to investigate the effects of inhaled ciclesonide administered for 2 weeks at doses ranging from 450 to 2700 μg twice daily or 3712.5 μg once daily. Systemic dexamethasone (0.066 mg/kg per os) was our positive control. A placebo group was also studied. Lung function and clinical scores were blindly performed before and after 7 and 14 days of treatment. Serum cortisol was measured before and after 3, 5, 7, 10, 14 days of treatment as well as 3 and 7 days post treatment.

resultsAfter 7 days, dexamethasone induced a significant reduction in pulmonary resistance (from 2.5 ± 0.6 at day 0 to 1.1 ± 0.7 cm H MAIN LIMITATIONS: Experimentally induced asthma exacerbations in horses might respond differently to treatment than naturally occurring exacerbations.

conclusionsInhaled ciclesonide is an effective treatment for horses with equine asthma. Serum cortisol was unaffected by treatment.

Indexed as

Administration, InhalationAnimalsCross-Over StudiesDose-Response Relationship, DrugGlucocorticoidsHorse DiseasesHorsesHydrocortisoneLung Diseases, ObstructivePregnenedionesciclesonideGlucocorticoidsHydrocortisonePregnenedionescortisolhorseinhalation therapyinhaled corticosteroidslung functionRAO

Identifiers

PMID30854685
PMCPMC7379559
OpenAlexW2921686820

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.